Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations. | bioRxiv | 2023 | 37577595 | PubTator, text mining | PubMed |
| Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes. | bioRxiv | 2023 | 37577509 | PubTator, text mining | PubMed |
| Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes. | Virus Evol | 2023 | 37577211 | PubTator, text mining | PubMed |
| Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis. | Diagnostics (Basel) | 2023 | 37568867 | PubTator, text mining | PubMed |
| Mutational Signatures in Gastric Cancer and Their Clinical Implications. | Cancers (Basel) | 2023 | 37568604 | PubTator, text mining | PubMed |
| Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism. | J Virol | 2023 | 37565748 | PubTator, text mining | PubMed |
| APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1. | mBio | 2023 | 37555667 | PubTator, text mining | PubMed |
| Particulate matter impairs immune system function by up-regulating inflammatory pathways and decreasing pathogen response gene expression. | Sci Rep | 2023 | 37550362 | PubTator, text mining | PubMed |
| Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis. | Cancer Med | 2023 | 37537783 | PubTator, text mining | PubMed |
| Analysis of somatic mutations and key driving factors of cervical cancer progression. | Open Med (Wars) | 2023 | 37533736 | PubTator, text mining | PubMed |
| Genetic inhibitors of APOBEC3B-induced mutagenesis. | Genome Res | 2023 | 37532520 | PubTator, text mining | PubMed |
| APOBEC3A drives resistance. | Nat Rev Drug Discov | 2023 | 37524811 | PubTator, text mining | PubMed |
| Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia. | iScience | 2023 | 37520727 | PubTator, text mining | PubMed |
| Pulsed Electromagnetic Fields (PEMF)-Physiological Response and Its Potential in Trauma Treatment. | Int J Mol Sci | 2023 | 37510998 | PubTator, text mining | PubMed |
| The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. | Genes (Basel) | 2023 | 37510234 | PubTator, text mining | PubMed |
| Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour. | Microbiome | 2023 | 37496039 | PubTator, text mining | PubMed |
| Increased interregional virus exchange and nucleotide diversity outline the expansion of chikungunya virus in Brazil. | Nat Commun | 2023 | 37479700 | PubTator, text mining | PubMed |
| Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. | Cancer Cell | 2023 | 37478850 | PubTator, text mining | PubMed |
| Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection. | Cancer Prev Res (Phila) | 2023 | 37477495 | PubTator, text mining | PubMed |
| Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage. | J Biol Chem | 2023 | 37474103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=12